Dow Jones/Wall Street Journal reports that GlaxoSmithKline announced Tuesday it has partnered with three non-governmental organizations to address the shortage of primary health care providers in least developed countries (LDCs). According to the article, GSK will work with AMREF in East and Southern Africa, CARE International U.K. in the Asia Pacific, and Save the Children in West Africa. The goal “of the investments will be to improve health outcomes by supporting frontline health workers who operate in these countries” (Baba, 5/24).

According to a GSK press release, these partnerships are “part of [the company’s] commitment to reinvest 20% of profits” made in LDCs back into the countries (5/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.